Cited by 430Metabolism, Diabetes, and CancerDiabetes Treatment and ManagementPancreatic and Hepatic Oncology Research

The DOI matches its Crossref record; 88 of the 89 references it cites were found in a registry or an index, and 1 are not checked yet.

Metformin Therapy and Risk of Cancer in Patients with Type 2 Diabetes: Systematic Review

Open access

Franciosi, Monica, Lucisano, Giuseppe, Lapice, Emanuela, Strippoli, Giovanni F. M., Pellegrini, Fabio, Nicolucci, Antonio·2013·PLoS ONE

DOI 10.1371/journal.pone.0071583PMC PMC3732236

Open this paper in CoChat — free account Open PDF

Abstract

AIMS/HYPOTHESIS: Diabetes treatments were related with either an increased or reduced risk of cancer. There is ongoing debate about a potential protective action of metformin. To summarize evidence on the association between metformin and risk of cancer and cancer mortality in patients with diabetes. DATA SOURCE: MEDLINE and EMBASE (January 1966-April 2012). We selected randomized studies comparing metformin and other hypoglycaemic agents and observational studies exploring the association between exposure to metformin and cancer. Outcomes were cancer mortality, all malignancies and site-specific cancers. RESULTS: Of 25307 citations identified, 12 randomized controlled trials (21,595 patients) and 41 observational studies (1,029,389 patients) met the inclusion criteria. In observational studies there was a significant association of exposure to metformin with the risk of cancer death [6 studies, 24,410 patients, OR:0.65, 95%CI: 0.53-0.80], all malignancies [18 studies, 561,836 patients, OR:0.73, 95%CI: 0.61-0.88], liver [8 studies, 312,742 patients, OR:0.34; 95%CI: 0.19-0.60] colorectal [12 studies, 871,365 patients, OR:0.83, 95%CI: 0.74-0.92], pancreas [9 studies, 847,248 patients, OR:0.56, 95%CI: 0.36-0.86], stomach [2 studies, 100701 patients, OR:0.83, 95%CI: 0.76-0.91], and esophagus cancer [2 studies, 100694 patients, OR:0.90, 95%CI: 0.83-0.98]. No significant difference of risk was observed in randomized trials. Metformin was not associated with the risk of: breast cancer, lung cancer, ovarian cancer, uterus cancer, prostate cancer, bladder cancer, kidney cancer, and melanoma. CONCLUSIONS/INTERPRETATION: Results suggest that Metformin might be associated with a significant reduction in the risk of cancer and cancer-related mortality. Randomized trials specifically designed to evaluate the efficacy of metformin as an anticancer agent are warranted.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0071583

Cites

88 of 89 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
(1998) · The Lancet · doi:10.1016/s0140-6736(98)07037-8 · Cited by 8,247
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1. The Cochrane Collaboration
Higgins, J., Green, S. R., & Higgins, J. (2008) · Cited by 5,544
Cochrane Handbook for Systematic Reviews of Interventions
Tarsilla, M. (2010) · Journal of MultiDisciplinary Evaluation · doi:10.56645/jmde.v6i14.284 · Cited by 5,232
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy
Nathan, D. M., Buse, J. B., Davidson, M. B., Ferrannini, E., Holman, R. R., Sherwin, R., & Zinman, B. (2009) · Diabetes Care · doi:10.2337/dc08-9025 · Cited by 3,834
Metformin and reduced risk of cancer in diabetic patients
Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005) · BMJ · doi:10.1136/bmj.38415.708634.f7 · Cited by 2,388
Case-Control Studies: Design, Conduct, Analysis.
Youkeles, L., & Schlesselman, J. J. (1983) · Journal of the American Statistical Association · doi:10.2307/2288156 · Cited by 2,358
Drug delivery with carbon nanotubes for in vivo cancer treatment
Liu, Z., Chen, K., Davis, C. R., Sherlock, S. P., Cao, Q., Chen, X. S., & Dai, H. (2008) · PubMed · doi:10.48550/arxiv.0808.2070 · Cited by 2,287

Flagged first, then by citations

Show all 89 references

Research works printed but not linked: 1

S Jiralerspong, 2009, Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breastcancer, J Clin Oncol, 27, 3297, 10.1200/JCO.2009.19.6410 · DOI · Paper page

Sorted by citations

Items 301–400 of 430

14-3-3zeta is involved in the anticancer effect of metformin in colorectal carcinoma
Ding, J., Zhu, Y., Yang, L., Tang, J., Wang, Y., Chen, Y., Cheng, K., Liu, J., Zhang, Y.-N., Li, Z., et al. (2018) · Carcinogenesis · doi:10.1093/carcin/bgy008 · Cited by 10
Pilot study of oral metformin in cancer‐bearing cats
Wypij, J. M. (2015) · Veterinary and Comparative Oncology · doi:10.1111/vco.12169 · Cited by 10
Mechanisms of Action of Metformin
Mahmood, S. A. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.99189 · Cited by 10
Obesity, Diabetes and Gastrointestinal Malignancy: The role of Metformin and other Anti-diabetic Therapy
McFarlane, S. (2018) · Global Journal of Obesity Diabetes and Metabolic Syndrome · doi:10.17352/2455-8583.000032 · Cited by 10
Bisphosphonates Zometa and Fosamax Synergize with Metformin to Prevent AOM-Induced Colon Cancer in F344 Rat Model
Madka, V., Kumar, G., Pathuri, G., Zhang, Y., Lightfoot, S. A., Asch, A. S., Mohammed, A., Steele, V. E., & Rao, C. V. (2019) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-19-0265 · Cited by 10
Synergic Effect of Metformin and Everolimus on Mitochondrial Dynamics of Renal Cell Carcinoma
Hong, S. H., Lee, K. S., Hwang, H.-J., Park, S.-Y., Han, W. K., & Yoon, Y. E. (2022) · Genes · doi:10.3390/genes13071211 · Cited by 9
Obesity, diabetes and aggressive prostate cancer hormone- naïve at initial diagnosis
Francesco, S. D., & Tenaglia, R. L. (2013) · Editor-in-Chief s Voice List of Authors is an Important Element in a Scientific Publication · doi:10.5173/ceju.2013.04.art7 · Cited by 9
Combination of metformin and oxaliplatin inhibits gastric cancer cell proliferation and induces apoptosis
Zhu, M., Wang, J., & Zhou, R. (2022) · Acta Biochimica Polonica · doi:10.18388/abp.2020_5750 · Cited by 9
Metformina: más allá del control glucémico
de Colombia, U. N., Morantes-Caballero, J. A., Londoño-Zapata, G. A., de Colombia, U. N., Rivera, M. R., de Colombia, U. N., Pinilla-Roa, A. E., & de Colombia, U. N. (2017) · Revista Médicas UIS · doi:10.18273/revmed.v30n1-2017005 · Cited by 9
Metformin improves survival in patients with concurrent diabetes and small cell lung cancer: a meta-analysis
Fan, H., Shikun, B. A. I., Guan, X., Wen, M. A., Fu, Y., Zhang, X., Lili, D. E. N. G., & Tian, J. (2021) · Minerva Endocrinology · doi:10.23736/s2724-6507.21.03289-2 · Cited by 9
In vivo and in vitro studies evaluating the chemopreventive effect of metformin on the aryl hydrocarbon receptor-mediated breast carcinogenesis
Alhoshani, A., Alotaibi, M. R., Sobeai, H. M. A., Alharbi, N., Alhazzani, K., Al‐Dhfyan, A., Alanazi, F. E., & Korashy, H. M. (2021) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2021.08.051 · Cited by 9
Navigating therapeutic prospects by modulating autophagy in colorectal cancer
Rajendran, D., & Oon, C. E. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.123121 · Cited by 8
Metformin: A Dual-Role Player in Cancer Treatment and Prevention: A Comprehensive Systematic Review and Meta-Analysis
Rangraze, I. R., Wali, A. F., El‐Tanani, M., Patni, M. A., Rabbani, S. A., Babiker, R. A., Satyam, S. M., El‐Tanani, Y., & Rizzo, M. (2025) · Medicina · doi:10.3390/medicina61061021 · Cited by 8
Close multilevel links between metabolic dysfunction-associated steatotic liver disease and type 2 diabetes mellitus
Holleboom, A. G., Francque, S., Cusi, K. J., & Caussy, C. (2025) · Metabolism Open · doi:10.1016/j.metop.2025.100424 · Cited by 8
Exposure to Commonly Used Drugs and the Risk of Gastric Cancer: An Umbrella Review of Meta-Analyses
Bai, X., Ding, S., Zhang, X., Han, M.-H., & Dai, D. (2023) · Cancers · doi:10.3390/cancers15020372 · Cited by 8
Carcinoma of the Ovaries and Fallopian Tubes
Coleman, R. L., Liu, J., Matsuo, K., Thaker, P. H., Westin, S. N., & Sood, A. K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-47674-4.00086-4 · Cited by 8
Psychische und neurokognitive Erkrankungen und Diabetes mellitus (Update 2023)
Abrahamian, H., Kautzky‐Willer, A., Rießland-Seifert, A., Lebherz-Eichinger, D., Fasching, P., Ebenbichler, C. F., Kautzky, A., & Toplak, H. (2023) · Wiener klinische Wochenschrift · doi:10.1007/s00508-022-02117-9 · Cited by 8
Therapeutic potential of the antidiabetic drug metformin in small bowel adenocarcinoma
Chiyo, T., Kato, K., Iwama, H., Fujihara, S., Fujita, K., Tadokoro, T., Oura, K., Samukawa, E., Yamana, Y., Kobayashi, N., et al. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.3971 · Cited by 8
Effective Cellular Transport of Ortho-Halogenated Sulfonamide Derivatives of Metformin Is Related to Improved Antiproliferative Activity and Apoptosis Induction in MCF-7 Cells
Markowicz-Piasecka, M., Komeil, I. A., Huttunen, J., Sikora, J., & Huttunen, K. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072389 · Cited by 8
Avoiding Time-Related Biases: A Feasibility Study on Antidiabetic Drugs and Pancreatic Cancer Applying the Parametric g-Formula to a Large German Healthcare Database
Börnhorst, C., Reinders, T., Rathmann, W., Bongaerts, B. W. C., Haug, U., Didelez, V., & Kollhorst, B. (2021) · Clinical Epidemiology · doi:10.2147/clep.s328342 · Cited by 8
The Complex Connection between Obesity and Cancer: Signaling Pathways and Therapeutic Implications
El‐Tanani, M., Rabbani, S. A., Aljabali, A. A. A., Matalka, I. I., El‐Tanani, Y., Rizzo, M., & Tambuwala, M. M. (2024) · Nutrition and Cancer · doi:10.1080/01635581.2024.2361964 · Cited by 7
Metformin use associated with lower risk of cancer in patients with diabetes mellitus type 2
Kusturica, J., Kulo, A., Gušić, E., Kapo, S. M., Rakanović-Todić, M., & Šečić, D. (2017) · Medicinski Glasnik · doi:10.17392/910-17 · Cited by 7
Increased kidney cancer risk in diabetes mellitus patients: a population-based cohort study in Lithuania
Undžytė, G., Patašius, A., Linkevičiūtė-Ulinskienė, D., Zabulienė, L., Stukas, R., Dulskas, A., & Smailytė, G. (2020) · The Aging Male · doi:10.1080/13685538.2020.1755249 · Cited by 7
Establishment of a rapid drug screening system based on embryonic stem cells
Hong, E., Choi, Y., Yang, H. J., Kang, H. Y., Ahn, C., & Jeung, E. (2014) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2014.12.003 · Cited by 7
Early pancreatic carcinogenesis – risk factors, early symptoms, and the impact of antidiabetic drugs
Fric, P., Škrha, J., Šedo, A., Bušek, P., Kmochová, K., Laclav, M., Solař, S., Bunganič, B., & Zavoral, M. (2016) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000646 · Cited by 7
Gastrointestinal disorders in diabetes
Marathe, C. S., Rayner, C. K., Wu, T., Jones, K. L., & Horowitz, M. (2020) · MDText.com, Inc. eBooks · Cited by 7
Using EHR-Linked Biobank Data to Study Metformin Pharmacogenomics
Breitenstein, M. K., Simon, G., Ryu, E., Armasu, S. M., Weinshilboum, R. M., Liewei, W., & Pathak, J. (2015) · Studies in health technology and informatics · doi:10.3233/978-1-61499-512-8-914 · Cited by 7
Predicting Pathologic Response in Locally Advanced Rectal Cancer Using Inflammatory, Nutritional, and Sarcopenia-Based Markers: A Regression and AI-Based Analysis (CINR-AI Study)
Uyar, G. C., Başaran, B. N., Başkurt, K., Yeşilbaş, E., Özkan, E., Yucel, K. B., Altınbaş, M., Evrimler, Ş., Öksüzoğlu, B. Ç., & Sütçüoğlu, O. (2025) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2025.10.002 · Cited by 6
Metformin/glibenclamide-related interstitial lung disease: a case report.
Zuccarini, G., Bocchino, M., Assante, L. R., Rea, G., & Sanduzzi, A. (2014) · Sarcoidosis vasculitis and diffuse lung diseases · Cited by 6
Optimizing clinical outcomes resulting from glucose‐lowering therapies in type 2 diabetes: increased confidence about the DPP ‐4 inhibitors and continued concerns regarding sulphonylureas and exogenous insulin
Currie, C. J., & Holden, S. E. (2014) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12349 · Cited by 6
Metformin alters therapeutic effects in the BALB/c tumor therapy model
Meyer, F., Goebel, S., Spangel, S. B., Leovsky, C., Hoelzer, D., & Thierbach, R. (2021) · BMC Cancer · doi:10.1186/s12885-021-08354-x · Cited by 6
Antidiabetic medications use and cancer risk in type 2 diabetes
Dąbrowski, M., Szymańska‐Garbacz, E., Miszczyszyn, Z., Dereziński, T., & Czupryniak, L. (2017) · Clinical Diabetology · doi:10.5603/dk.2017.0004 · Cited by 6
Changes in glucose-lowering drug use before and after cancer diagnosis in patients with diabetes
Zanders, M. M. J., Haak, H. R., van Herk‐Sukel, M. P. P., Herings, R. M. C., van de Poll-Franse, L. V., & Johnson, J. A. (2017) · Diabetes & Metabolism · doi:10.1016/j.diabet.2017.08.004 · Cited by 6
Impact of metformin on melanoma: a meta-analysis and systematic review
Feng, H., Shang, S., Chen, K., Sun, X., & Yue, X. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1399693 · Cited by 5
Metformin Versus Sulfonylurea in Breast Cancer Risk of Diabetic Patients: A Systematic Review and Meta-Analysis
Moradi-Joo, M., Mohabbat-Bahar, S., Heidari, S., Davoodi, S. H., Sheyklo, S. G., & Akbari, M. E. (2016) · Iranian Journal of Cancer Prevention · doi:10.17795/ijcp-5971 · Cited by 5
Differences in risk factors of malignancy between men and women with type 2 diabetes: A retrospective case-control study
Dąbrowski, M., Szymańska‐Garbacz, E., Miszczyszyn, Z., Dereziński, T., & Czupryniak, L. (2017) · Oncotarget · doi:10.18632/oncotarget.17716 · Cited by 5
Comparative study between the effects of some dietary sources and metformin drug on weight reduction in obese rats
Mosa, Z. M., El-Badry, Y. A.-M., Fatah, H. S. A., & Mohamed, E. G. (2015) · Annals of Agricultural Science Cairo · doi:10.1016/j.aoas.2015.11.001 · Cited by 5
Association of Metformin With Volumetric Tumor Growth of Sporadic Vestibular Schwannomas
Armstrong, M. F., Lohse, C. M., Lees, K. A., & Carlson, M. L. (2021) · Otology & Neurotology · doi:10.1097/mao.0000000000003149 · Cited by 5
A review on the molecular mechanisms and pharmacology of andrographolide from Andrographis paniculata (Burm.f.) Nees in the management of the interplay between type 2 diabetes and breast cancer
Abdullah, S., & Chatterjee, P. K. (2025) · Phytomedicine Plus · doi:10.1016/j.phyplu.2025.100772 · Cited by 4
Synergistic Anticancer Effects of Metformin and Doxorubicin in Ovarian Cancer Cells Through Dual Apoptotic Pathway Activation and Oxidative Stress Enhancement
Akalın, S. A., Afşin, Y., Toprak, V., Özdemır, İ., Tuncer, M. C., & Öztürk, Ş. (2025) · Biology · doi:10.3390/biology14121749 · Cited by 4
Investigating the association between glycaemic traits and colorectal cancer in the Japanese population using Mendelian randomisation
Hanyuda, A., Goto, A., Katagiri, R., Koyanagi, Y. N., Nakatochi, M., Sutoh, Y., Nakano, S., Oze, I., Ito, H. M., Yamaji, T., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-33966-7 · Cited by 4
Efficacy of metformin drug in preventing metabolic syndrome associated with androgen deprivation therapy (ADT) in prostate cancer patients: A systematic review and meta-analysis
Yakout, I. A., Gallab, M. M., Mohamed, D. A., Hamdar, H., Ibrahim, S. I., Mohamed, A., Abdelshafi, A., & Abd‐ElGawad, M. (2024) · Seminars in Oncology · doi:10.1053/j.seminoncol.2024.10.001 · Cited by 4
Metformin and the risk of cancer in type 2 diabetes: methodological challenges and perspectives.
Yang, X., & Chan, J. C. N. (2014) · PubMed Central · doi:10.3978/j.issn.2305-5839.2014.06.07 · Cited by 4
Metformin for Castrate-resistant Prostate Cancer: Learning More About an Old Dog's New Tricks
Hamilton, R. J. (2014) · European Urology · doi:10.1016/j.eururo.2014.01.013 · Cited by 4
A Retrospective Study of the Effect of Metformin on Patients with Metastatic Prostate Cancer
Lee, C., Lam, S. Y., Liu, A., Sison, C. P., & Zhu, X. (2023) · Clinical Medicine Insights Oncology · doi:10.1177/11795549231152073 · Cited by 4
Chemoprevention strategies in hereditary breast and ovarian cancer syndromes
Barbieri, E., Venturelli, M., Mastrodomenico, L., Piombino, C., Ponzoni, O., Zaniboni, S., Barban, S., Razzaboni, E., Grandi, G., Dominici, M., et al. (2024) · Tumori Journal · doi:10.1177/03008916241274721 · Cited by 3
Clinical Effect of Treatment with Metformin for Type 2 Diabetes on Non-Small Cell Lung Cancer Patients Undergoing Immunotherapy: A Retrospective Study
Wang, Y., Sun, Y., Hu, J., & Ma, H. (2024) · International Journal of General Medicine · doi:10.2147/ijgm.s495449 · Cited by 3
A nem alkoholos zsírmájbetegség és a 2-es típusú cukorbetegség.
Pár, A., Wittmann, I., & Pár, G. (2022) · Orvosi Hetilap · doi:10.1556/650.2022.32480 · Cited by 3
Metformina: stary lek w nowej aplikacji
Dmoszyńska, A., Podhorecka, M., & Giannopoulos, K. (2016) · Acta Haematologica Polonica · doi:10.1016/j.achaem.2016.04.001 · Cited by 3
EFFECT OF METFORMIN, MELATONIN AND THEIR COMBINATIONS WITH PACLITAXEL ON THE GROWTH OF TRANSPLANTABLE HER2-POSITIVE BREAST TUMOR IN FEMALE FVB/N MICE
Osipov, M., Semiglazova, Т. Y., Popovich, I. G., Панченко, А. В., Тындык, М. Л., Zabezhinskiy, M., Klimenko, V. V., Стуков, А. Н., & Anisimov, V. N. (2017) · Voprosy Onkologii · doi:10.37469/0507-3758-2017-63-4-650-654 · Cited by 3
Metformin use and the Risk of Gastrointestinal Malignancies in Diabetic Populations: A Meta-Analysis
Gil, H., Samara, S., Zhyvotovska, A., & McFarlane, S. (2020) · International Journal of Clinical Endocrinology and Metabolism · doi:10.17352/ijcem.000052 · Cited by 3
Metformin Therapy and Breast Cancer Incidence in the Ha’il Region
Osman, M. E., Muqbel, T., Abduallh, A., Alanazi, S., Khalifa, N. E., Khojali, W. M. A., Elagib, H. M., Hussein, W., & Abdallah, M. H. (2023) · Healthcare · doi:10.3390/healthcare11030321 · Cited by 3
The Effect of Metformin on Vestibular Schwannoma Growth: A Systematic Review and Meta‐analysis
Lovin, B. D., Wilkinson, A. J., Qing, Y., Hernández, M., Nader, M., Raza, S. M., DeMonte, F., & Gidley, P. W. (2023) · The Laryngoscope · doi:10.1002/lary.30601 · Cited by 3
Diabetes Mellitus and Colon Carcinogenesis: Expectation for Inhibition of Colon Carcinogenesis by Oral Hypoglycemic Drugs
Kato, J., Shirakami, Y., & Shimizu, M. (2019) · Gastrointestinal Disorders · doi:10.3390/gidisord1020023 · Cited by 3
Comparative Study of in vitro Anti-proliferative Activity of Metformin, Teneligliptin, and Canagliflozin against Breast Cancer Cell Line
Venugopal, G., Kumaravelu, P., & Ramya, S. (2025) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.1177/0976500x251319832 · Cited by 2
Additive Anticancer and Antioxidant Effects of Metformin and Luteolin in Breast and Colorectal Cancer Cell Lines
Gębczak, K., Cwynar-Zając, Ł., Sapeta-Nowińska, M., & Barg, E. (2025) · Pharmaceuticals · doi:10.3390/ph18111660 · Cited by 2
Prevention of Colorectal Neoplasia
Dolejs, S. C., Gayed, B. N., & Fajardo, A. D. (2016) · Clinics in Colon and Rectal Surgery · doi:10.1055/s-0036-1584086 · Cited by 2
Genetic association of type 2 diabetes and antidiabetic drug target with skin cancer
Zhao, J., Zhang, Y., Li, J., Li, Q., & Teng, Z. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1445853 · Cited by 2
Association of metformin use with risk and survival outcome of esophageal cancer in patients with diabetes: A systematic review and meta-analysis
Xie, H., Li, M., Chen, Z., & Zheng, Y. (2025) · PLoS ONE · doi:10.1371/journal.pone.0310687 · Cited by 2
Alteration of metabolic activity regulates mitochondrial temperature in diagnosis in HepG2 hepatocellular carcinoma cells
Gaser, O. A., Nasr, M. A., Hussein, A. E., Salah, R. A., Saad, S. M., Ehab, S., Aboomar, N. M., Elmehrath, A. O., Salah, A., Chang, Y.-T., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-02807-0 · Cited by 2
Hype versus Hope: Metformin and Vitamin D as Anticancer Agents
Lohmann, A. E., & Goodwin, P. J. (2014) · American Society of Clinical Oncology Educational Book · doi:10.14694/edbook_am.2014.34.e69 · Cited by 2
Le risque de cancer associé aux médicaments du diabète de type 2 (metformine, sulfonylurées et insulines)
Faillie, J., & Bringer, J. (2014) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(14)70833-8 · Cited by 2
Insulin, Other Hypoglycemic Drugs, and Glucagon
Escaño, A. K. (2015) · Side effects of drugs annual · doi:10.1016/bs.seda.2015.05.006 · Cited by 2
Commentary: metformin use is associated with reduced gastric cancer risk
de Vries, A. C., & Kuipers, E. J. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12723 · Cited by 2
Metformin for recurrent colorectal polyp or adenoma prevention after polypectomy in patients without diabetes mellitus: a prospective study
Wang, W., Luo, B., Wang, Z., Zhang, J., Zhou, Y., He, X.-J., Li, D., & Sun, D. (2025) · Neoplasma · doi:10.4149/neo_2025_250319n130 · Cited by 1
Effects of Metformin on Cancer Survival Among Men Diagnosed with Advanced Prostate Cancer Treated with Androgen-Deprivation Therapy: Emulating a Target Trial
López, D. S., Polychronopoulou, E., Abdelgadir, O., Greenberg, R. S., Cowell, L. G., Messiah, S. E., & Kuo, Y. (2025) · Cancers · doi:10.3390/cancers17213579 · Cited by 1
Metformin in gastrointestinal cancers and inflammatory bowel disease: Unraveling its mechanisms and therapeutic applications
Li, Y., Xingqi, G., Dong, X., Xia, T., Ma, S., & Liu, Z. (2026) · iScience · doi:10.1016/j.isci.2026.114877 · Cited by 1
Effectiveness of Metformin in Preventing Colorectal Cancer Among J apanese Patients With Type 2 Diabetes: A Target Trial Emulation
Hiroki, S., Fukasawa, T., Honda, M., & Kawakami, K. (2026) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.70429 · Cited by 1
Mouse Models to Study Metformin Effects in Carcinogenesis
Schneider, A. (2015) · Energy balance and cancer · doi:10.1007/978-3-319-16733-6_13 · Cited by 1
Mechanisms Underlying Physiological Functions of Food Factors via Non-specific Interactions with Biological Proteins
Murakami, A. (2015) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.14-00208-3 · Cited by 1
The Impact of Cancer Treatments on Aging
Lee, C. D., & Longo, V. D. (2015) · Springer eBooks · doi:10.1007/978-3-319-23246-1_4 · Cited by 1
The use of metformin in the treatment of gastrointestinal cancer
Ткач, С. М. (2021) · Clinical endocrinology and endocrine surgery · doi:10.30978/cees-2021-3-60 · Cited by 1
Review of Drug Repositioning in Cancer Therapeutics
Kharwade, S. B., Ruikar, D. B., Manekar, S. S., & Shahane, N. P. (2024) · Asian Journal of Research in Chemistry · doi:10.52711/0974-4150.2024.00042 · Cited by 1
Modeling for the Care of Complex Patients.
Nataraj, N. (2017) · NCSU Libraries Repository (North Carolina State University Libraries) · Cited by 1
Administration of metformin in clinical medicine; an updated mini-review on current findings
Hedaiaty, M. (2018) · Journal of Nephropharmacology · doi:10.15171/npj.2018.14 · Cited by 1
To Be Healthy, Wealthy, and Wise: Using Decision Modeling to Personalize Policy in Health, Hunger Relief, and Education
Ivy, J. S., Capan, M., Hicklin, K., Nataraj, N., Orgut, I. S., Craig, A., & Vila-Parrish, A. R. (2019) · Women in engineering and science · doi:10.1007/978-3-030-11866-2_11 · Cited by 1
Long-Term Metformin Effect on Endometrial Cancer Development Depending on Glucose Environment In Vitro
Weber, A. M., Lange, C., Jauckus, J., Strowitzki, T., & Germeyer, A. (2021) · Open Journal of Obstetrics and Gynecology · doi:10.4236/ojog.2021.119111 · Cited by 1
Cancer Metabolism
Wahl, D. R., & Venneti, S. (2017) · Springer eBooks · doi:10.1007/978-3-319-61401-4_6 · Cited by 1
Polypharmacology in Clinical Applications—Anticancer Polypharmacology
Wang, Z., & Yang, B. (2022) · Springer eBooks · doi:10.1007/978-3-031-04998-9_3 · Cited by 1
Synthesis and encapsulation of 1,3,5-triazine derivatives as anticancer agent
Chalermnon, M. (2020) · Chula Digiverse · doi:10.58837/chula.the.2020.100 · Cited by 1
METFORMIN AND SULFONYLUREAS EFFECT ON THE BLOOD LEVEL OF PROSTATE SPECIFIC ANTIGEN
Mohammed, M. E. A., Ahme, Y. E., & Ali, I. H. (2015) · Asian Journal of Pharmaceutical and Clinical Research
Quantifying the associations between diabetes mellitus, glycated haemoglobin and incidence of and mortality from cancer: analysis of longitudinal data from England and Scotland linked to Cancer Registry and mortality data
Gordon-Dseagu, V. (2014) · UCL Discovery (University College London)
The Relationship of Type 2 Diabetes, Oral Diabetes Medications, and Insulin Therapy to Risk for Breast Cancer
Stankowski‐Drengler, T. J., Stankowski, R. V., Engel, J. M., & Onitilo, A. A. (2013) · Current Nutrition Reports · doi:10.1007/s13668-013-0066-y
Mortalität bei Diabetespatienten unter Metformin- oder Sulfonylharnstofftherapie und bei Personen ohne Diabetes
Jecht, M. (2014) · Der Diabetologe · doi:10.1007/s11428-014-1312-7
Chemoprevention of prostate cancer: what have we learned?
Hamilton, R. J. (2014) · Trends in Urology & Men s Health · doi:10.1002/tre.415
The effects of hyperglycemia on glucose metabolism in epithelial ovarian cancer
Kellenberger, L. D. (2016) · The Atrium (University of Guelph)
Uso de metformina e a ocorrência de neoplasias em pacientes com Diabetes Mellitus pré-existente
de Carvalho, T. A. M. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2016.tde-08122015-164514
Rational Combinations of mTOR Inhibitors as Anticancer Strategies
García-Donás, J., Rodríguez-Moreno, J. F., Romero-Laorden, N., & Hidalgo, M. M. (2015) · Springer eBooks · doi:10.1007/978-2-8178-0492-7_9
Metformin: A Potential Chemosensitizing Agent for Improving Castration-resistant Prostate Cancer Treatment
Mayer, M. (2016) · TSpace (University of Toronto)
Estudio de la ruta de la autofagia en carcinoma de endometrio esporádico
Prieto, M. F. (2016) · doi:10.14201/gredos.132924
Consequence of Energy Imbalance in Prostate Cancer and Comorbidities
Schenk, J. M., & Wright, J. L. (2017) · Energy balance and cancer · doi:10.1007/978-3-319-64940-5_3
Characterizing the Role of Insulin Signalling in Advanced Prostate Cancer
Sarkar, P. L. (2017) · Queensland University of Technology · doi:10.5204/thesis.eprints.110524
Metformin: Hype or Hope for Cancer
Nar, A. (2017) · International Journal of Hematology and Oncology · doi:10.4999/uhod.171870
The Prevention and Control of Cancer by Metformin in Patients with Type 2 Diabetes: A Systematic Mapping ReviewPreprint
Mitchell, A., Price, M., & Cipriano, G. C. (2021) · medRxiv · doi:10.1101/2021.06.04.21258310
The relationship between metformin exposure, prostate cancer and race/ethnicity
Chen, C. B. (2016) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3vq2sm82
Nuevas aproximaciones en el estudio de la ruta autofágica en cáncer colorrectal
Perdomo, V. C. R. (2018) · Gredos (University of Salamanca) · doi:10.14201/gredos.137357
Type 2 diabetes mellitus and gastrointestinal cancer
de Jong (2019) · Research Publications (Maastricht University) · doi:10.26481/dis.20190605rj
O papel da exclusão duodenal na regulação dos níveis glicêmicos em pacientes diabéticos tipo 2 submetidos a gastrectomia com reconstrução em Y de Roux por câncer gástrico
Franciss, M. Y. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2019.tde-04062019-143507
Research Progress on Anti-Tumor Effect of Metformin in Gastric Cancer
贺, 礼. (2019) · Advances in Clinical Medicine · doi:10.12677/acm.2019.97128
Intoxication à la metformine
Simon, M., Baudry, T., Hernu, R., Cour, M., & Argaud, L. (2019) · Médecine Intensive Réanimation · doi:10.3166/rea-2019-0127

Authors: Franciosi, M., Lucisano, G., Lapice, E., Strippoli, G. F. M., Pellegrini, F., & Nicolucci, A.
Affiliations: University of Naples Federico II (IT)
The University of Sydney (AU)
Corresponding author: Franciosi, Monica
ORCID: Strippoli, Giovanni F. M.
Pellegrini, Fabio
Nicolucci, Antonio
Venue: PLoS ONE
Publisher: Public Library of Science (PLoS)
Published: 2013-08-02
Volume: 8
Issue: 8
Pages: e71583
ISSN: 1932-6203 (ISSN-L)
DOI: 10.1371/journal.pone.0071583
PMC: PMC3732236
OpenAlex: W2081540191
Cited by: 428
References: 89
Citations by year: 2026: 8 · 2025: 18 · 2024: 19 · 2023: 27 · 2022: 18 · 2021: 29 · 2020: 31 · 2019: 36 · 2018: 31 · 2017: 44 · 2016: 51 · 2015: 59 · 2014: 52 · 2013: 5
FWCI: 5.23
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by
creativecommons.org/licenses/by/4.0/ (unspecified)
Locations: PLoS ONE (publishedVersion, cc-by)
Europe PMC (PubMed Central) (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
RePEc: Research Papers in Economics (submittedVersion)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Figshare (submittedVersion, cc-by)
CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro) (submittedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
Keywords: type 2 diabetes, cancer risk, cancer mortality, liver cancer, colorectal cancer, pancreatic cancer, gastric cancer, esophageal cancer, site-specific cancer, chemoprevention, antidiabetic drugs, drug safety, randomized controlled trials, observational studies, breast cancer, lung cancer, ovarian cancer, prostate cancer, bladder cancer, kidney cancer, melanoma
MeSH terms: Diabetes Mellitus, Type 2, Humans, Hypoglycemic Agents, Metformin, Neoplasms, Risk Factors, Meta-Analysis as Topic, Randomized Controlled Trials as Topic, Diabetes Complications

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Metformin Therapy and Risk of Cancer in Patients with Type 2 Diabetes: Systematic Review

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks